Loading clinical trials...
Loading clinical trials...
An Open Label, Randomized Study to Compare Antiretroviral Therapy (ART) Initiation When CD4 is Between 15% to 24% to ART Initiation When CD4 Falls Below 15% in Children With HIV Infection and Moderate Immune Suppression
Conditions
Interventions
Abacavir
Efavirenz
+5 more
Locations
9
Cambodia
National Pediatric Hosp., Cambodia CIPRA CRS
Phnom Penh, Cambodia
Social Health Clinic, Cambodia CIPRA CRS
Phnom Penh, Cambodia
Hiv-Nat Cipra Crs
Pathumwan, Bangkok, Thailand
Chiang Rai Regional Hosp. CIPRA CRS
Muang, Changwat Chiang Rai, Thailand
Prapokklao Hosp. CIPRA CRS
Chanthaburi, Thailand
Nakornping Hosp. CIPRA CRS
Chiang Mai, Thailand
Start Date
April 1, 2006
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
December 4, 2013
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions